{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:48:07Z","timestamp":1780447687876,"version":"3.54.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T00:00:00Z","timestamp":1611446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T00:00:00Z","timestamp":1611446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Clinical Research Award of First Affiliated Hospital of Xi\u2019an Jiaotong University, China","award":["XJTU1AF-CRF-2015-009"],"award-info":[{"award-number":["XJTU1AF-CRF-2015-009"]}]},{"name":"Clinical Research Award of First Affiliated Hospital of Xi\u2019an Jiaotong University, China","award":["XJTU1AF-CRF-2016-011"],"award-info":[{"award-number":["XJTU1AF-CRF-2016-011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00705-021-04960-z","type":"journal-article","created":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T11:02:27Z","timestamp":1611486147000},"page":"853-862","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Distribution of human papillomavirus genotypes in western China and their association with cervical cancer and precancerous lesions"],"prefix":"10.1007","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8137-0382","authenticated-orcid":false,"given":"Jiao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0388-6006","authenticated-orcid":false,"given":"Juan-Juan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5915-0551","authenticated-orcid":false,"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8763-9912","authenticated-orcid":false,"given":"Ya-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,24]]},"reference":[{"issue":"6","key":"4960_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4960_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.amepre.2018.03.013","volume":"55","author":"F Guo","year":"2018","unstructured":"Guo F, Cofie LE, Berenson AB (2018) Cervical cancer incidence in young U.S. females after human papillomavirus vaccine introduction. Am J Prev Med 55(2):197\u2013204. https:\/\/doi.org\/10.1016\/j.amepre.2018.03.013","journal-title":"Am J Prev Med"},{"issue":"5","key":"4960_CR3","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359-386. https:\/\/doi.org\/10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"issue":"2","key":"4960_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115\u2013132. https:\/\/doi.org\/10.3322\/caac.21338","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"4960_CR5","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1158\/1055-9965.EPI-11-1158","volume":"21","author":"CM Pierce Campbell","year":"2012","unstructured":"Pierce Campbell CM, Menezes LJ, Paskett ED, Giuliano AR (2012) Prevention of invasive cervical cancer in the United States: past, present, and future. Cancer Epidemiol Biomark Prev 21(9):1402\u20131408. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-1158","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"9","key":"4960_CR6","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.7150\/jca.14971","volume":"7","author":"Z Zeng","year":"2016","unstructured":"Zeng Z, Yang H, Li Z, He X, Griffith CC, Chen X, Guo X, Zheng B, Wu S, Zhao C (2016) Prevalence and genotype distribution of HPV infection in China: analysis of 51,345 HPV genotyping results from China\u2019s largest CAP Certified Laboratory. J Cancer 7(9):1037\u20131043. https:\/\/doi.org\/10.7150\/jca.14971","journal-title":"J Cancer"},{"issue":"6","key":"4960_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study G (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518\u2013527. https:\/\/doi.org\/10.1056\/NEJMoa021641","journal-title":"N Engl J Med"},{"issue":"9","key":"4960_CR8","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/jnci\/92.9.690","volume":"92","author":"H zur Hausen","year":"2000","unstructured":"zur Hausen H (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92(9):690\u2013698. https:\/\/doi.org\/10.1093\/jnci\/92.9.690","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4960_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","volume":"324","author":"EM de Villiers","year":"2004","unstructured":"de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324(1):17\u201327. https:\/\/doi.org\/10.1016\/j.virol.2004.03.033","journal-title":"Virology"},{"issue":"11","key":"4960_CR10","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menendez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez GI, Nowakowski AM, Bornstein J, Munoz N, Bosch FX, Retrospective International S, Group HPVTTS (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11(11):1048\u20131056. https:\/\/doi.org\/10.1016\/S1470-2045(10)70230-8","journal-title":"Lancet Oncol"},{"issue":"12","key":"4960_CR11","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S1473-3099(17)30468-1","volume":"17","author":"K Kavanagh","year":"2017","unstructured":"Kavanagh K, Pollock KG, Cuschieri K, Palmer T, Cameron RL, Watt C, Bhatia R, Moore C, Cubie H, Cruickshank M, Robertson C (2017) Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study. Lancet Infect Dis 17(12):1293\u20131302. https:\/\/doi.org\/10.1016\/S1473-3099(17)30468-1","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"4960_CR12","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1016\/S2468-2667(17)30222-0","volume":"3","author":"A Castanon","year":"2018","unstructured":"Castanon A, Landy R, Pesola F, Windridge P, Sasieni P (2018) Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study. Lancet Public Health 3(1):e34\u2013e43. https:\/\/doi.org\/10.1016\/S2468-2667(17)30222-0","journal-title":"Lancet Public Health"},{"issue":"5","key":"4960_CR13","doi-asserted-by":"publisher","first-page":"e023897","DOI":"10.1136\/bmjopen-2018-023897","volume":"9","author":"C Zhu","year":"2019","unstructured":"Zhu C, Wang Y, Mao W, Zhang H, Ma J (2019) Prevalence and distribution of HPV types in genital warts in Xi\u2019an, China: a prospective study. BMJ Open 9(5):e023897. https:\/\/doi.org\/10.1136\/bmjopen-2018-023897","journal-title":"BMJ Open"},{"issue":"2","key":"4960_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1128\/JCM.02274-14","volume":"53","author":"HC Low","year":"2015","unstructured":"Low HC, Silver MI, Brown BJ, Leng CY, Blas MM, Gravitt PE, Woo YL (2015) Comparison of Hybribio GenoArray and Roche human papillomavirus (HPV) linear array for HPV genotyping in anal swab samples. J Clin Microbiol 53(2):550\u2013556. https:\/\/doi.org\/10.1128\/JCM.02274-14","journal-title":"J Clin Microbiol"},{"issue":"5","key":"4960_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/cncy.21521","volume":"123","author":"R Nayar","year":"2015","unstructured":"Nayar R, Wilbur DC (2015) The Pap test and Bethesda 2014. Cancer Cytopathol 123(5):271\u2013281. https:\/\/doi.org\/10.1002\/cncy.21521","journal-title":"Cancer Cytopathol"},{"issue":"7","key":"4960_CR16","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/1055-9965.EPI-07-2922","volume":"17","author":"RP Insinga","year":"2008","unstructured":"Insinga RP, Liaw KL, Johnson LG, Madeleine MM (2008) A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States. Cancer Epidemiol Biomark Prev 17(7):1611\u20131622. https:\/\/doi.org\/10.1158\/1055-9965.EPI-07-2922","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"8","key":"4960_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e","volume":"17","author":"RG Newcombe","year":"1998","unstructured":"Newcombe RG (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17(8):857\u2013872. https:\/\/doi.org\/10.1002\/(sici)1097-0258(19980430)17:8%3c857::aid-sim777%3e3.0.co;2-e","journal-title":"Stat Med"},{"issue":"20","key":"4960_CR18","doi-asserted-by":"publisher","first-page":"15386","DOI":"10.18632\/oncotarget.24169","volume":"9","author":"HH Xu","year":"2018","unstructured":"Xu HH, Wang K, Feng XJ, Dong SS, Lin A, Zheng LZ, Yan WH (2018) Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis. Oncotarget 9(20):15386\u201315397. https:\/\/doi.org\/10.18632\/oncotarget.24169","journal-title":"Oncotarget"},{"issue":"6","key":"4960_CR19","doi-asserted-by":"publisher","first-page":"e014135","DOI":"10.1136\/bmjopen-2016-014135","volume":"7","author":"HH Xu","year":"2017","unstructured":"Xu HH, Lin A, Chen YH, Dong SS, Shi WW, Yu JZ, Yan WH (2017) Prevalence characteristics of cervical human papillomavirus (HPV) genotypes in the Taizhou area, China: a cross-sectional study of 37 967 women from the general population. BMJ Open 7(6):e014135. https:\/\/doi.org\/10.1136\/bmjopen-2016-014135","journal-title":"BMJ Open"},{"issue":"45","key":"4960_CR20","doi-asserted-by":"publisher","first-page":"e13206","DOI":"10.1097\/MD.0000000000013206","volume":"97","author":"L Yao","year":"2018","unstructured":"Yao L, Yuan M, Yuan J, Zhou P, Mei L, Cheng J (2018) Analysis of cervical human papillomavirus infection in 2300 women in Urumqi, China. Medicine (Baltimore) 97(45):e13206. https:\/\/doi.org\/10.1097\/MD.0000000000013206","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"4960_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12879-017-2223-1","volume":"17","author":"L Zhang","year":"2017","unstructured":"Zhang L, Bi Q, Deng H, Xu J, Chen J, Zhang M, Mu X (2017) Human papillomavirus infections among women with cervical lesions and cervical cancer in Eastern China: genotype-specific prevalence and attribution. Bmc Infect Dis 17(1):107. https:\/\/doi.org\/10.1186\/s12879-017-2223-1","journal-title":"Bmc Infect Dis"},{"issue":"3","key":"4960_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/jmv.25331","volume":"91","author":"M Li","year":"2019","unstructured":"Li M, Du X, Lu M, Zhang W, Sun Z, Li L, Ye M, Fan W, Jiang S, Liu A, Wang M, Meng Y, Li Y (2019) Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing. China. J Med Virol 91(3):473\u2013481. https:\/\/doi.org\/10.1002\/jmv.25331","journal-title":"China. J Med Virol"},{"issue":"2","key":"4960_CR23","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10552-013-0320-z","volume":"25","author":"SK Kjaer","year":"2014","unstructured":"Kjaer SK, Munk C, Junge J, Iftner T (2014) Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS\/LSIL, HSIL, or cervical cancer: what is the potential for prevention? Cancer Causes Control 25(2):179\u2013189. https:\/\/doi.org\/10.1007\/s10552-013-0320-z","journal-title":"Cancer Causes Control"},{"issue":"5","key":"4960_CR24","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1002\/ijc.29085","volume":"136","author":"V Smelov","year":"2015","unstructured":"Smelov V, Elfstrom KM, Johansson AL, Eklund C, Naucler P, Arnheim-Dahlstrom L, Dillner J (2015) Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial. Int J Cancer 136(5):1171\u20131180. https:\/\/doi.org\/10.1002\/ijc.29085","journal-title":"Int J Cancer"},{"issue":"1","key":"4960_CR25","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","volume":"89","author":"GM Clifford","year":"2003","unstructured":"Clifford GM, Smith JS, Aguado T, Franceschi S (2003) Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89(1):101\u2013105. https:\/\/doi.org\/10.1038\/sj.bjc.6601024","journal-title":"Br J Cancer"},{"issue":"4","key":"4960_CR26","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/ijc.31261","volume":"143","author":"K Cuschieri","year":"2018","unstructured":"Cuschieri K, Ronco G, Lorincz A, Smith L, Ogilvie G, Mirabello L, Carozzi F, Cubie H, Wentzensen N, Snijders P, Arbyn M, Monsonego J, Franceschi S (2018) Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs. Int J Cancer 143(4):735\u2013745. https:\/\/doi.org\/10.1002\/ijc.31261","journal-title":"Int J Cancer"},{"issue":"3 Suppl 2","key":"4960_CR27","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ygyno.2008.07.045","volume":"110","author":"X Castellsague","year":"2008","unstructured":"Castellsague X (2008) Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol 110(3 Suppl 2):S4-7. https:\/\/doi.org\/10.1016\/j.ygyno.2008.07.045","journal-title":"Gynecol Oncol"},{"issue":"1","key":"4960_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc2050","volume":"7","author":"CB Woodman","year":"2007","unstructured":"Woodman CB, Collins SI, Young LS (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7(1):11\u201322. https:\/\/doi.org\/10.1038\/nrc2050","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"4960_CR29","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1128\/JCM.33.8.2058-2063.1995","volume":"33","author":"CE Greer","year":"1995","unstructured":"Greer CE, Wheeler CM, Ladner MB, Beutner K, Coyne MY, Liang H, Langenberg A, Yen TS, Ralston R (1995) Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol 33(8):2058\u20132063","journal-title":"J Clin Microbiol"},{"issue":"1","key":"4960_CR30","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-9378-7-38","volume":"7","author":"B Serrano","year":"2012","unstructured":"Serrano B, Alemany L, Tous S, Bruni L, Clifford GM, Weiss T, Bosch FX, de Sanjose S (2012) Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agent Cancer 7(1):38. https:\/\/doi.org\/10.1186\/1750-9378-7-38","journal-title":"Infect Agent Cancer"},{"issue":"6","key":"4960_CR31","doi-asserted-by":"publisher","first-page":"477","DOI":"10.21147\/j.issn.1000-9604.2017.06.02","volume":"29","author":"X Li","year":"2017","unstructured":"Li X, Zheng R, Li X, Shan H, Wu Q, Wang Y, Chen W (2017) Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014. Chin J Cancer Res 29(6):477\u2013486. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2017.06.02","journal-title":"Chin J Cancer Res"},{"key":"4960_CR32","doi-asserted-by":"publisher","first-page":"l4508","DOI":"10.1136\/bmj.l4508","volume":"366","author":"M Martinez-Lavin","year":"2019","unstructured":"Martinez-Lavin M (2019) HPV vaccine: adverse event signals were minimised or ignored. BMJ 366:l4508. https:\/\/doi.org\/10.1136\/bmj.l4508","journal-title":"BMJ"},{"issue":"10","key":"4960_CR33","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s10067-017-3768-5","volume":"36","author":"M Martinez-Lavin","year":"2017","unstructured":"Martinez-Lavin M, Amezcua-Guerra L (2017) Serious adverse events after HPV vaccination: a critical review of randomized trials and post-marketing case series. Clin Rheumatol 36(10):2169\u20132178. https:\/\/doi.org\/10.1007\/s10067-017-3768-5","journal-title":"Clin Rheumatol"},{"issue":"1","key":"4960_CR34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.7326\/M19-1182","volume":"172","author":"JF Laprise","year":"2020","unstructured":"Laprise JF, Chesson HW, Markowitz LE, Drolet M, Martin D, Benard E, Brisson M (2020) Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45 years in the United States. Ann Intern Med 172(1):22\u201329. https:\/\/doi.org\/10.7326\/M19-1182","journal-title":"Ann Intern Med"},{"issue":"2 Suppl","key":"4960_CR35","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.ygyno.2008.02.002","volume":"109","author":"TC Wright Jr","year":"2008","unstructured":"Wright TC Jr, Huh WK, Monk BJ, Smith JS, Ault K, Herzog TJ (2008) Age considerations when vaccinating against HPV. Gynecol Oncol 109(2 Suppl):S40-47. https:\/\/doi.org\/10.1016\/j.ygyno.2008.02.002","journal-title":"Gynecol Oncol"},{"issue":"6","key":"4960_CR36","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1093\/cid\/cix475","volume":"65","author":"EA Burger","year":"2017","unstructured":"Burger EA, Kim JJ, Sy S, Castle PE (2017) Age of acquiring causal human papillomavirus (HPV) infections: leveraging simulation models to explore the natural history of HPV-induced cervical cancer. Clin Infect Dis 65(6):893\u2013899. https:\/\/doi.org\/10.1093\/cid\/cix475","journal-title":"Clin Infect Dis"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-021-04960-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-021-04960-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-021-04960-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T22:44:55Z","timestamp":1613688295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-021-04960-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,24]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["4960"],"URL":"https:\/\/doi.org\/10.1007\/s00705-021-04960-z","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,24]]},"assertion":[{"value":"23 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Institutional Review Board of the First Affiliated Hospital of Xi\u2019an Jiaotong University (XJTU1AF2016LSL-043).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable in this research, which is based on retrospective data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}